Targeted antiangiogenic therapy for cancer using Vitaxin: a humanized monoclonal antibody to the integrin alphavbeta3. (Q40616267)
scientific article published on August 2000
Language:
(P31) (Q13442814)
(P304) 3056-3061
(P407) (Q1860)
(P433) 8
(P478) 6
(P577) Tuesday, August 1, 2000
(P921) (Q79460)
(Q574834)
(P1433) (Q332253)
(P1476) "Targeted antiangiogenic therapy for cancer using Vitaxin: a humanized monoclonal antibody to the integrin alphavbeta3" (language: en)
(P2093) Gutheil JC
Campbell TN
Pierce PR
Watkins JD
Huse WD
Bodkin DJ
Cheresh DA
other details
description scientific article published on August 2000

External Links